There were significant improvements in all groups in terms of the post-treatment Functional Status Scale score ( p < 0.05 for all groups ) , Symptom Severity Scale score ( first group : p < 0.05 , second group : p < 0.01 , third group : p < 0.001 ) and Visual Analogue Scale score ( first and third groups : p < 0.01 , second group : p < 0.001 ) .